Xerava
Xerava Shows Promise For Treating CRAB
Combination therapy with eravacycline shows favorable clinical and microbiological outcomes among patients with ...
OCTOBER 24, 2022
Take Advantage of Newer Antibiotic Options
Antibiotic-resistant infections and deaths increased by 15% during the pandemic, according to the Infectious ...
OCTOBER 13, 2022
Treating IAIs in Patients at High Risk for Poor Outcomes
Melanie Olesky, PhD, discusses an antibiotic study presented at the 2019 annual MAD-ID (Making a Difference in ...
JUNE 4, 2019
Xerava Shown Effective in High-Risk Patients With cIAIs
Xerava was effective in treating patients with complicated intra-abdominal infectionswho had characteristics that ...
JUNE 4, 2019
Xerava Effective in Eradicating Organism, Curing cIAIs
Xerava showed similar eradication results as the comparator agents in patients with cIAIs.
DECEMBER 7, 2018
FDA Approves Xerava for Complicated Intraabdominal Infections
The FDA approved Xerava to treat complicated intraabdominal infections in those 18 years old and older.
AUGUST 28, 2018
